MedPath

A comparison of vaitarana Basti and matra basti in the disease Amavata called Rheumatoid arthritis in modern science

Not Applicable
Conditions
Health Condition 1: null- joint pain and swelling over there
Registration Number
CTRI/2018/02/011865
Lead Sponsor
DIRECTOR ISMH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

PATIENTS HAVING CLASSICAL SIGNS AND SYMPTOMS OF AMAVATA.

THE BASE OF CRITERIA LED DOWN BY AMERICAN RHEUMATISM ASSOCIATION ARA WAS ALSO TAKEN INTO CONSIDERATIO

Exclusion Criteria

PATIENTS SUFFERING FROM SYSTEMIC DISORDERS LIKE HTN DM ETC WHICH MAY LEAD TO FATAL CONDITION

PATIENTS OF CHRONIC CONDITION MORE THAN 10 YEARS

PATIENTS HAVING SEVER DIFORMITY

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All signs and symptoms of AMAVATA were assigned score depending upon there severity to assess the effect of the drugs at the time of before treatment and after treatment.Timepoint: 16 days
Secondary Outcome Measures
NameTimeMethod
Basti of Bruhatsaindhvadi taila which was used in matra basti form was more effective than Vaitarana basti.Timepoint: after 16 days of administration
© Copyright 2025. All Rights Reserved by MedPath